Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study

BACKGROUND: In 2017, an estimated 14 million cases of Plasmodium vivax malaria were reported from Asia, Central and South America, and the Horn of Africa. The clinical burden of vivax malaria is largely driven by its ability to form dormant liver stages (hypnozoites) that can reactivate to cause rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Devine, Angela, Battle, Katherine E., Meagher, Niamh, Howes, Rosalind E., Dini, Saber, Gething, Peter W., Simpson, Julie A., Price, Ric N., Lubell, Yoel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168905/
https://www.ncbi.nlm.nih.gov/pubmed/34061843
http://dx.doi.org/10.1371/journal.pmed.1003614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168905/
https://www.ncbi.nlm.nih.gov/pubmed/34061843
http://dx.doi.org/10.1371/journal.pmed.1003614

Ejemplares similares